Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Phase I trial of LY-CovMab in China completes enrollment

Jan. 19, 2021

Shanghai Institute of Materia Medica dicloses new hepatitis B virus inhibitors

Jan. 19, 2021

Murine model of SARS-CoV-2 infection developed via mRNA transfection of hACE2

Jan. 19, 2021

First patient dosed in phase II study of alisporivir in early-stage COVID-19

Jan. 19, 2021

Grifols to begin clinical evaluation of new COVID-19 treatment

Jan. 19, 2021

Overactive immunity can increase susceptibility to fungal infections

Jan. 18, 2021

Trying to stay ahead of SARS-CoV-2 as variants emerge

Jan. 18, 2021

Phase I/II results for COVID-19 vaccine Ad26.COV2.S support its further development

Jan. 15, 2021

Investigators present new antibodies for malaria

Jan. 15, 2021

CanSino Biologics patents glycoconjugates as vaccines for pneumococcal infections

Jan. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...